Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Fell 2.80%, with the Latest Price at HKD 13.560
Newtimespace News: As of 11:22 on May 18, the Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) fell 2.80%, with the latest price at HKD 13.560, a high of HKD 13.930, a low of HKD 13.540, an average price of HKD 13.671, assets under management of approximately HKD 2.172 billion, a latest net asset value of HKD 13.992, and a discount of 0.30%.
The Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) tracks the Hang Seng Biotech Index, which consists of listed companies in biotech, pharmaceuticals, and healthcare sectors in Hong Kong, reflecting the overall performance of Hong Kong's biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Zhejiang Shimai Pharmaceutical Refiles for Hong Kong IPO; Core Products DNV3 and SMET12 in Clinical Stage
- W.I.S.E. - CSI HK 100 Tracker (02825.HK) Fell 1.47%, with the Latest Price at HKD 29.500
- Chinaamc Solana ETF(03460.HK) Fell 6.91% to 3.424
- Hang Seng TECH Index ETF(03032.HK) Fell 2.48% to 4.800
- Global X MSCI China ETF (03040.HK) Fell 1.46%, with the Latest Price at HKD 34.980